87 research outputs found
INFLUÊNCIA DA ASSIMETRIA DE INFORMAÇÃO NA ESTRUTURA DE CAPITAL EM EMPRESAS BRASILEIRAS
As discussões acerca da estrutura de capital surgiram no início da década de 1950 sendo o objeto de estudo os problemas de medição dos custos de capital que suportasse a continuidade das operações da empresa. A estrutura de capital é discutida sobre duas principais vertentes teóricas, a Trade Off Theory e a Pecking Order Theory. Conforme a Pecking Order Theory (Myers, 1984) um importante determinante das decisões de financiamento das organizações, é a informação assimétrica presente no mercado de capitais, pois quando as organizações decidem sobre a forma de financiamento, essas transmitem informações ao mercado demonstrando a associação entre estes dois elementos. Sob essa perspectiva a presente pesquisa teve por objetivo analisar a influência da assimetria de informação na determinação da estrutura de capital em empresas brasileiras de capital aberto listadas na BM&FBovespa no período de 2009 a 2015. Os resultados evidenciaram que a assimetria da informação possui influência na determinação da estrutura de capital. Este resultado foi obtido pela verificação da variável nível de governança corporativa como sendo importante na determinação da estrutura de capital no primeiro grupo de empresas que possuem listagem em níveis de governança corporativa. Por outro lado, quando analisadas as empresas que não estão listadas em níveis de governança corporativa e tampouco emissão de ADR, a variável Bid-Ask apresenta influência significativa na determinação da estrutura de capital deste grupo. Cabe inferir que tais achados remetem a pouca importância dada à variável Bid-Ask na determinação da estrutura de capital em empresas que possuem mecanismos de controle interno eficientes. Como é o caso das empresas que estão listadas em níveis de governança corporativa ou que possuem emissão de ADR
Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance
Quality of life and mortality from a nephrologist's view: a prospective observational study
<p>Abstract</p> <p>Background</p> <p>Although health-related quality of life (HRQOL) is a potential independent predictor of mortality, nephrologists have shown little interest in HRQOL with respect to mortality in chronic kidney disease (CKD). The aim of this article is to evaluate the impact of HRQOL on mortality in the elderly, who are likely to develop or already have CKD.</p> <p>Methods</p> <p>Among 1,000 randomly sampled participants aged more than 65 years (sourced from the Korean Longitudinal Study on Health and Ageing), 944 subjects were evaluated for HRQOL. HRQOL was assessed using a 36-item Short-Form health survey (SF36). A cumulative survival rate was calculated according to tertiles of SF36 scores and classified by the presence of CKD (estimated GFR <60 ml/min/1.73 m<sup>2</sup>).</p> <p>Results</p> <p>Among 944 subjects, 46.6% had CKD. CKD patients had lower total and physical component scores compared with subjects without CKD. The 3-year cumulative survival rate was 90.0% (non-CKD vs. CKD: 92.6% vs. 87.4%, <it>P </it>= 0.005 by log rank test). After adjusting for multiple variables, a reduced SF36 score (physical and mental components) was a strong predictor of all-cause mortality. Physical components were consistently able to predict mortality after CKD classification, but mental components were statistically significant only in the CKD group.</p> <p>Conclusion</p> <p>In addition to traditional risk factors of mortality, nephrologists should be aware of HRQOL as a predictor of mortality and should make efforts to improve HRQOL in CKD patients.</p
Chagas Cardiomiopathy: The Potential of Diastolic Dysfunction and Brain Natriuretic Peptide in the Early Identification of Cardiac Damage
Chagas disease remains a major cause of morbidity and mortality in several
countries of Latin America and has become a potential public health problem in
countries where the disease is not endemic as a result of migration flows.
Cardiac involvement represents the main cause of mortality, but its diagnosis is
still based on nonspecific criteria with poor sensitivity. Early identification
of patients with cardiac damage is desirable, since early treatment may improve
prognosis. Diastolic dysfunction and elevated brain natriuretic peptide levels
are present in different cardiomyopathies and in advanced phases of Chagas
disease. However, there are scarce data about the role of these parameters in
earlier forms of the disease. We conducted a study to assess the diastolic
function, regional systolic abnormalities and brain natriuretic peptide levels
in the different forms of Chagas disease. The main finding of our investigation
is that diastolic dysfunction occurs before any cardiac dilatation or motion
abnormality. In addition, BNP levels identify patients with diastolic
dysfunction and Chagas disease with high specificity. The results reported in
this study could help to early diagnose myocardial involvement and better
stratify patients with Chagas disease
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
The mammalian target of rapamycin (mTOR) is an intracellular serine/threonine protein kinase positioned at a central point in a variety of cellular signaling cascades. The established involvement of mTOR activity in the cellular processes that contribute to the development and progression of cancer has identified mTOR as a major link in tumorigenesis. Consequently, inhibitors of mTOR, including temsirolimus, everolimus, and ridaforolimus (formerly deforolimus) have been developed and assessed for their safety and efficacy in patients with cancer. Temsirolimus is an intravenously administered agent approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) for the treatment of advanced renal cell carcinoma (RCC). Everolimus is an oral agent that has recently obtained US FDA and EMEA approval for the treatment of advanced RCC after failure of treatment with sunitinib or sorafenib. Ridaforolimus is not yet approved for any indication. The use of mTOR inhibitors, either alone or in combination with other anticancer agents, has the potential to provide anticancer activity in numerous tumor types. Cancer types in which these agents are under evaluation include neuroendocrine tumors, breast cancer, leukemia, lymphoma, hepatocellular carcinoma, gastric cancer, pancreatic cancer, sarcoma, endometrial cancer, and non-small-cell lung cancer. The results of ongoing clinical trials with mTOR inhibitors, as single agents and in combination regimens, will better define their activity in cancer
A Live-Attenuated HSV-2 ICP0− Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
Glycoprotein D (gD-2) is the entry receptor of herpes simplex virus 2 (HSV-2), and is the immunogen in the pharmaceutical industry's lead HSV-2 vaccine candidate. Efforts to prevent genital herpes using gD-2 subunit vaccines have been ongoing for 20 years at a cost in excess of $100 million. To date, gD-2 vaccines have yielded equivocal protection in clinical trials. Therefore, using a small animal model, we sought to determine if a live-attenuated HSV-2 ICP0− virus would elicit better protection against genital herpes than a gD-2 subunit vaccine. Mice immunized with gD-2 and a potent adjuvant (alum+monophosphoryl lipid A) produced high titers of gD-2 antibody. While gD-2-immunized mice possessed significant resistance to HSV-2, only 3 of 45 gD-2-immunized mice survived an overwhelming challenge of the vagina or eyes with wild-type HSV-2 (MS strain). In contrast, 114 of 115 mice immunized with a live HSV-2 ICP0− virus, 0ΔNLS, survived the same HSV-2 MS challenges. Likewise, 0ΔNLS-immunized mice shed an average 125-fold less HSV-2 MS challenge virus per vagina relative to gD-2-immunized mice. In vivo imaging demonstrated that a luciferase-expressing HSV-2 challenge virus failed to establish a detectable infection in 0ΔNLS-immunized mice, whereas the same virus readily infected naïve and gD-2-immunized mice. Collectively, these results suggest that a HSV-2 vaccine might be more likely to prevent genital herpes if it contained a live-attenuated HSV-2 virus rather than a single HSV-2 protein
Supernova remnants: the X-ray perspective
Supernova remnants are beautiful astronomical objects that are also of high
scientific interest, because they provide insights into supernova explosion
mechanisms, and because they are the likely sources of Galactic cosmic rays.
X-ray observations are an important means to study these objects.And in
particular the advances made in X-ray imaging spectroscopy over the last two
decades has greatly increased our knowledge about supernova remnants. It has
made it possible to map the products of fresh nucleosynthesis, and resulted in
the identification of regions near shock fronts that emit X-ray synchrotron
radiation.
In this text all the relevant aspects of X-ray emission from supernova
remnants are reviewed and put into the context of supernova explosion
properties and the physics and evolution of supernova remnants. The first half
of this review has a more tutorial style and discusses the basics of supernova
remnant physics and thermal and non-thermal X-ray emission. The second half
offers a review of the recent advances.The topics addressed there are core
collapse and thermonuclear supernova remnants, SN 1987A, mature supernova
remnants, mixed-morphology remnants, including a discussion of the recent
finding of overionization in some of them, and finally X-ray synchrotron
radiation and its consequences for particle acceleration and magnetic fields.Comment: Published in Astronomy and Astrophysics Reviews. This version has 2
column-layout. 78 pages, 42 figures. This replaced version has some minor
language edits and several references have been correcte
Non-Standard Errors
In statistics, samples are drawn from a population in a data-generating process (DGP). Standard errors measure the uncertainty in estimates of population parameters. In science, evidence is generated to test hypotheses in an evidence-generating process (EGP). We claim that EGP variation across researchers adds uncertainty: Non-standard errors (NSEs). We study NSEs by letting 164 teams test the same hypotheses on the same data. NSEs turn out to be sizable, but smaller for better reproducible or higher rated research. Adding peer-review stages reduces NSEs. We further find that this type of uncertainty is underestimated by participants
- …